18th Jun 2014 11:09
LONDON (Alliance News) - Biopharmaceutical company Oxford BioMedica PLC said Wednesday that it had repaid the full amount drawn down from its GBP5 million loan facility agreement with its largest shareholder following its recent equity fund-raising. Oxford said Monday it had raised GBP21.6 Read More